During the past decade, Ajou University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ajou University Hospital" are "Active Systemic Lupus Erythematosus" (1 trials), "Chronic Spontaneous Urticaria" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Systemic Lupus Erythematosus (SLE)" (1 trials). Many other conditions were trialed in "Ajou University Hospital" in a lesser frequency.

Most popular intervention types in "Ajou University Hospital" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Efavaleukin Alfa" (1 trials), "Evolocumab" (1 trials), "Omalizumab" (1 trials) and "Placebo for Rozibafusp Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ajou University Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ajou University Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ajou University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ajou University Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".